TP53 and endometrial cancer: The majority of endometrial cancers are diagnosed at an early stage and the 5-year overall survival rate for patients with localised disease is high (95%), However, endometrial cancers with high-risk factors such as high-grade serous pathology and TP53 mutation have a tendency to recur.1